Vanda Pharmaceuticals (VNDA) Stock Price Target 2026

The average analyst price target for Vanda Pharmaceuticals is $13.07, 224.3% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $7.50 to $20. The latest change came on Sep 23, 2026, when Oppenheimer initiated coverage of Vanda Pharmaceuticals with an Outperform rating and a $10 price target.